Caption Management, LLC Geron Corp Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $3.85 Million - $4.59 Million	1,895,500 Added 57.82%	5,173,900 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $581,494 - $1.02 Million	348,200 Added 11.88%	3,278,400 $7.67 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $919,989 - $1.28 Million	773,100 Added 35.84%	2,930,200 $4.54 Million
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $2.14 Million - $3.45 Million	2,157,100 New	2,157,100 $2.94 Million
Q1 2019 May 14, 2019	SELL	$1.01 - $1.83 $284,921 - $516,243	-282,100 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$0.98 - $1.85 $1.17 Million - $2.21 Million	-1,191,900 Reduced 80.86%	282,100 $283,000
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $2.22 Million - $8.03 Million	1,259,000 Added 585.58%	1,474,000 $2.59 Million
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $707,350 - $1.04 Million	215,000 New	215,000 $737,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.14B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.